Physicians’ Opinions Survey on FDA’s Bydureon Approval

2012-03-06

Physicians were asked to assess their impressions of Bydureon in terms of efficacy, safety, tolerability, expected use, and other important factors. Key questions are broken down by specialty or familiarity to highlight difference in physician perceptions

Highlights

Datamonitor anticipates that the initial enthusiasm will ultimately be muted once physicians gain experience with the drug. Nevertheless, a once-weekly antidiabetic agent clearly represents an attractive option for type 2 diabetes patients, and physicians expect the drug to be a welcome addition to their armamentarium.

FDA’s Bydureon Approval

Published: February 2012
Price
: Single User License US$3800            Corporate User License – US$9500

                    Request Sample


Your key questions answered
  • Assess physicians’ opinions of Bydureon as compared with Amylin’s twice-daily Byetta (exenatide) and Novo Nordisk’s once-daily Victoza (liraglutide)
  • Determine physicians’ expectations for Bydureon’s uptake, line of therapy, and use in combination with other antidiabetics
  • Evaluate how Bydureon may expand the overall market for GLP-1 agonists

Table of Contents

BYDUREON FDA APPROVAL: PHYSICIAN OPINION
Background

SURVEY RESULTS
Demographics
Limited familiarity with PCPs could present a marketing challenge
Impressions of Bydureon’s efficacy differ based on familiarity
Tolerability issues trump safety concerns among physicians familiar with Bydureon
High expectations for Bydureon use will likely come down with increased experience
Endocrinologists expect to use Bydureon in earlier line of therapy compared to PCPs
Combination use with oral antidiabetics is likely
Physicians expect Bydureon to expand the GLP-1 agonist market
Conclusion

APPENDIX
Report methodology
Datamonitor consulting

Disclaimer

List of Figures

Figure: On average, how many patients with type 2 diabetes do you treat per month?
Figure: How familiar are you with Bydureon (once-weekly exenatide)?
Figure: For each attribute below, please select the one drug that you would prefer to prescribe, based on performance (or predicted performance) on that attribute
Figure: Please select the one drug that you would prefer to prescribe, based on efficacy (HbA1c lowering ability)
Figure: Please rank the following potential safety (and tolerability) issues you are most concerned about with Bydureon on a scale of 1 to 7, where 1 is the issue of greatest concern and 7 is the issue of least concern
Figure: Please select the one drug that you would prefer to prescribe, based on injection device
Figure: Where in the treatment algorithm do you think you will most commonly prescribe Bydureon?
Figure: Please consider your hypothetical Bydureon-treated patient population a year post-launch. What percentage of the Bydureon-treated patient population do you expect to have previously been treated with each of the following options?
Figure: Please choose up to three drug classes with which Bydureon could be used in combination. If there are more than three classes, please select the three most likely
Figure: Please give your opinion on how the introduction of Bydureon, and any other market trends, will impact on the number of patients on GLP-1 agonists in the US

Filed in: Pharmaceutical, Pharmaceuticals and Healthcare
More Reports
Title Price Buy Now

Global Herbal Supplements Market 2016-2020

About Herbal Supplements A type of dietary supplement made of herbs, or when parts of herbs are used in supplements for scent, flavor, or potential therapeutic properties. In dietary supplements, the demand for herbal supplements is growing because of the growing demand for natural products. The analysts forecast global herbal supplements market to grow at a CAGR of 6.29% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global herbal supplements market for 2016-2020. To calculate the market size, the report considers the revenue generated from from the sale of herbal supplements. The market is divided into the following segments based on geography: APAC Europe North America ROW The report, Global Herba......
$2500

Global Analgesics Market 2016-2020

About the Analgesics Market Analgesics are among the most commonly prescribed drugs for pain, especially that from fractures, ankle sprains, and other injuries. These are designed particularly for pain relief. Opioids, NSAIDs, and local anesthetics are the major analgesics used to treat pain. The long term use of analgesics has been linked to gastrointestinal problems. Pain is treated with analgesics, also called as pain killers, many of which are accessible without a prescription, including acetaminophen, aspirin, or ibuprofen. These medicines are termed as non-prescription or OTC analgesics and can be used either alone for mild pain or in combination with other medicines for severe pain. The analysts forecast global analgesics market to grow at a CAGR of 4.28% during the period 2016-20......
$2500

COPD Drugs Market in China 2016-2020

About the Chronic Obstructive Pulmonary Disease (COPD) Drugs Market in China Chronic obstructive pulmonary disease (COPD) is a broad term that covers progressive lung diseases, including emphysema, chronic bronchitis, refractory (non-reversible) asthma, and some forms of bronchiectasis. It restricts airflow in the lungs and is characterized by diffculty breathing. The exact etiology of COPD is not understood, but most cases are caused due to genetic factors and by inhaling pollutants, including smoke, fumes, and chemicals. As the disease develops, the symptoms tend to get worse and damages the lungs. The disease cannot be cured, and can only be managed and treated. The COPD drugs market in China is under penetrated. It is dominated by fixed dose combinations of LABA/ICS. Air pollution is......
$2500

Global Blood coagulation analyzer market 2016-2020

About the Blood Coagulation Analyzer Market A blood coagulation analyzer is a testing device used in clinical laboratories to test the coagulation efficacy of blood and assess bleeding disorders such as hemophilia, Von Willebrand disease (type 1, type 2, and type 3), Factor V Leiden thrombophilia disorder, polycythemia, leukemia, thrombus, and thrombocytopenia. The device is also used to diagnose patients with hemostatic disorders (both congenital and acquired) or identify the condition of thrombosis to treat and reduce complications. Additionally, the device is used to monitor patients who take anticoagulant medicines such as heparin, aspirin, and warfarin due to their side effects. For instance, heparin has to be constantly monitored to prevent the abrupt closing of any coronary artery ......
$2500

Global Vision Care Market 2016-2020

About the Vision Care Market Uncorrected refractive errors are the main cause of severe and moderate visual impairment, while eye conditions such as pink eye and cataracts (non-refractive errors) are the leading causes of blindness in middle- and low-income countries. The governments in many countries have introduced national programs and regulations to control and prevent visual impairment. Eye care services are easily available and are progressively being integrated into primary and secondary healthcare systems, which focus on the provision of high-quality services at affordable prices. For instance, Brazil has been providing eye care services through the national social security system since 2004, Morocco has been following up with the National Blindness Control Program since 1991, Ch......
$2500

Global Healthcare IT Market 2016-2020

About the Healthcare IT Market The adoption of connected healthcare solutions, such as electronic health record (EHR) and PHR, has increased with the rise in need to enhance the overall quality of healthcare services. Also, tightening of government regulations in the healthcare sector has fueled the adoption of IT solutions globally. Healthcare information technology outsourcing (ITO) solution providers will have to follow the guidelines of healthcare Acts applicable to their operating jurisdiction while delivering services. We anticipate that the high adoption of cloud computing ITO solutions and services should reduce the overall in-house IT costs. Through these solutions, healthcare providers will be able to implement business applications swiftly, while remaining focused on their core......
$2500

Global Bioactive Wound Care Market 2016-2020

About the Bioactive Wound Care Market Bioactive wound care products play a critical role in the wound healing process and are derived from the artificial or natural sources. These products are formed by combining different polymers such as collagen, alginates, and silicon. In the past, different natural and synthetic dressings such as cotton wool, bandages, lint, and gauzes with varying degrees of absorption were utilized in wound management. However, many advanced wound care products have been introduced in the market in the last two decades. The purpose of these wound dressings is to keep the wound dry by allowing the evaporation of exudates from the surface of the wounds and restricting the entry of harmful microorganisms. The analysts forecast global bioactive wound care market to gr......
$2500

Global H1N1 Vaccines Market 2016-2020

About the H1N1 Vaccines Market The high level of maturity in the H1N1 vaccines market has renewed the push to develop quadrivalent vaccines that address areas of the market with unmet medical needs. Vaccines that prevent H1N1 have been a long-standing void in the treatment algorithm. Therefore, the introduction advanced vaccines in the next decade will likely alter the global H1N1 vaccines market landscape. Sanofi, AstraZeneca, and VaxInnate have also invested in quadrivalent vaccines, such as Sanofi's VaxiGrip, VaxInnate's VAX2012Q, and AstraZeneca's MEDI-550 vaccine, which will impact the US and Europe markets during the forecast period. Other areas of opportunity for novel entrants include vaccines with improved immune response and immunogenic infant vaccines. The analysts forecast gl......
$2500

rhEPO Market in China 2016-2020

About the Recombinant Human Erythropoietin (rhEPO) Market in China Erythropoietin (EPO), also referred to as hematopoietin or hemopoietin, is a glycoprotein responsible for producing erythrocytes in the body. In the fetal stage, this protein is produced in the liver; it is secreted by the kidneys in adulthood. During anemic conditions, the body produces an excess of EPO, maintaining the normal levels of red blood cells (RBC). When the endogenous production of EPO is disturbed because of diseases or the use of medications, the normal RBC levels can be maintained by an external supply of EPO-stimulating agents (ESAs). These agents are similar to the natural EPO in structure and function and are administered as injections. They can be produced by recombinant DNA technology and are used to tr......
$2500

Global Healthcare BPO Market 2016-2020

About the Healthcare Business Process Outsourcing (BPO) Market BPO is a segment of outsourcing that consists of subcontracting business processes of an organization to a third-party vendor that has expertise in the required domain. These vendors then administer and manage the selected activity based on defined and measurable performance criteria. It helps clients increase their operational efficiency, concentrate on core competencies, reduce time-to-market, obtain access to fresh talent with experience in the latest technologies, and, in the long run, build an organization with an economical cost structure. Several healthcare providers adopt BPO services due to proven benefits of cost reduction, improved patient care services, and maximized staff efficiency. The analysts forecast global ......
$2500